How to read a pathology report you don't understand

Short answer: A pathology report tells you what the tissue actually is (diagnosis), how aggressive it looks (grade), how far it has spread in the sample (stage / margins), and any molecular markers that change treatment. Below is a plain-language walk-through of each section and what to ask your doctor about it.

A pathology report is often the first piece of paper that makes a diagnosis feel real — and it's usually written for other doctors, not for you. Terms like "invasive," "margins," "grade," and "receptor status" carry enormous weight, but nothing in the document explains what they actually mean for your specific situation.

If you're holding one right now and trying to figure out what it says, here's a plain-language walk-through of what's typically in one, what the most common terms mean, and what to do if yours still doesn't make sense.

What a pathology report actually is

A pathology report is written by a pathologist — a doctor who examines tissue, cells, or fluid under a microscope. When a biopsy, surgery, or fluid sample is taken, it goes to the pathology lab, where the pathologist studies it and writes up what they see. That report becomes the primary evidence for what your diagnosis is.

Your treating doctor (oncologist, surgeon, primary care physician) uses the pathology report to decide what to do next. That's why the words on it matter so much — every treatment recommendation you're about to hear traces back to this document.

The American Cancer Society's guide to pathology reports is a good companion piece if you want to go deeper on any of the sections below.

The basic sections you'll usually see

Specimen information. This describes what tissue was examined and where it came from. It's mostly administrative, but worth confirming it matches what you expected — the correct side (left vs. right), the correct location, the correct patient. Errors here are rare but not unheard of.

Clinical history. A short line or two about why the sample was taken — for example, "55-year-old woman with abnormal mammogram." This is context for the pathologist, not a diagnosis.

Gross description. What the tissue looked like to the naked eye before being processed — size, color, texture. Often written in technical language but rarely important for the patient.

Microscopic description. What the pathologist saw under the microscope. This is where the diagnostic reasoning lives, and it can be dense — cell shapes, patterns, staining results. Skim, don't dwell.

Diagnosis. This is the core of the report — the specific name of what was found. This single line often gets the most attention and the least explanation. If a term here is unfamiliar, that's the first thing worth asking about directly. The NCI Dictionary of Cancer Terms is a reliable place to look up individual words in plain English.

Tumor characteristics (if applicable). This section may include size, grade, and margins. More on each below. The College of American Pathologists' patient guide explains how these are measured.

Receptor or biomarker status (common in cancer pathology). These results — like hormone receptor status in breast cancer, or genetic markers like KRAS in colon cancer — often determine which treatments will actually work. This section can look like a wall of abbreviations and numbers, but it is frequently the most clinically important part of the report. MedlinePlus has plain-language explanations for many of the individual tests you'll see listed.

Staging information. If staging is included, it usually reflects how far the condition has progressed. Staging affects nearly every treatment decision that follows. The NCI overview of cancer staging explains the common systems in everyday language.

Comment or note. Sometimes the pathologist adds context — cases that were close calls, additional testing they recommend, or clarifications for the treating doctor. Worth reading; often the most human-language part of the report.

The terms that carry the most weight

A handful of words show up in almost every cancer pathology report and drive most of the treatment decisions. If you understand these, you understand roughly 80% of what the report is telling you.

Invasive vs. in situ. In situ ("in place") means the abnormal cells are still contained in the layer where they started — they haven't grown into surrounding tissue. Invasive means they've broken out. In situ disease is generally treated less aggressively than invasive disease.

Grade. How abnormal the cells look under the microscope and how quickly they're likely to grow. Grade 1 (well differentiated) means cells still look mostly normal. Grade 3 (poorly differentiated) means they've lost most of their normal features and often grow faster. Grade is different from stage — grade is about the cells themselves; stage is about how far the disease has spread.

Margins. The edges of the tissue removed by the surgeon. Clear (or negative) margins mean no abnormal cells were seen at the edge, suggesting the surgeon got all the visible disease. Positive (or involved) margins mean cells were present right at the edge, and additional treatment — more surgery, radiation, or both — may be needed. Close margins are a gray zone that your doctor will interpret.

Lymphovascular invasion (LVI). Whether cancer cells were seen inside small blood or lymph vessels near the tumor. Positive LVI can suggest higher risk of spread.

Nodes. If lymph nodes were removed, the report will say how many were examined and how many contained cancer (e.g. "2 of 15 nodes positive"). Node status is a major driver of stage and treatment.

Receptor status (breast cancer especially). ER+ and PR+ (estrogen and progesterone receptor positive) mean hormone therapies will likely work. HER2+ means HER2-targeted drugs like trastuzumab are options. Triple negative (ER-, PR-, HER2-) rules out those specific therapies but doesn't rule out treatment — it just means a different set of options.

Ki-67. A measure of how quickly cells are dividing. Higher numbers usually mean faster-growing disease.

Pathology report phrase decoder

Most people don't search for "grade" or "margins" — they search for the exact strange phrase sitting on their page. These are the literal strings that show up most often, and what each one actually signals.

"No dx found" / "no diagnosis found." Usually shorthand for no diagnosis — the pathologist did not identify a specific disease process in the sample. In most contexts this is reassuring, but it can also mean the sample missed the area of concern. Ask: "Does this mean the tissue is normal, or that we didn't sample the right spot?"

"No significant pathology." The tissue looks essentially normal — nothing abnormal enough to name. This is a normal result.

"Negative for malignancy." No cancer was seen in this sample. Note the wording: it describes the sample, not your whole body.

"Benign." Not cancer. Benign findings can still need treatment — a benign growth can press on something — but they don't spread.

"Atypical" / "atypia." The cells look abnormal but not clearly cancerous. This is the genuine gray zone, and it usually triggers either repeat sampling or closer follow-up. Always ask what the plan is for an atypical result.

"Dysplasia" (low-grade / high-grade). Disordered cell growth on a spectrum toward cancer. Low-grade is often monitored; high-grade is frequently treated.

"Suspicious for [X]." The pathologist thinks it's probably X but can't confirm it on this material. Additional testing or a larger sample usually follows.

"Consistent with [X]." The findings match X and the pathologist is confident, especially combined with your clinical picture.

"Favor [X]" / "most consistent with." A leaning, not a certainty. Worth asking what would settle it.

"Cannot exclude [X]." X hasn't been ruled out. This phrase alarms people more than it usually should — it's often careful hedging rather than real suspicion. Ask directly: "How likely is that, really?"

"Focal." Present in one small area only.

"Reactive changes" / "inflammatory." The tissue is responding to irritation, infection, or injury — not cancer.

"Nondiagnostic" / "insufficient for diagnosis" / "quantity not sufficient (QNS)." Not enough usable tissue to answer the question. This almost always means a repeat biopsy.

"Deferred to [pathologist]" or "pending immunostains." The case was sent for a specialist opinion or extra staining. Your report isn't final yet — ask when the addendum is expected.

"No residual carcinoma" / "complete pathologic response." After chemo or radiation given before surgery, no live cancer was found in the removed tissue. This is a genuinely good result.

"R0 / R1 / R2." Surgical completeness. R0 = no cancer at the margins. R1 = microscopic cancer at the margin. R2 = visible cancer left behind.

"pT2 N1 M0" (the pTNM line). The pathologic stage. T = tumor size or depth, N = lymph nodes involved, M = distant spread. The lowercase "p" means it's based on examined tissue rather than imaging, which makes it more accurate than a clinical stage.

"Well / moderately / poorly differentiated." The plain-English version of grade. Well differentiated = looks close to normal, usually slower. Poorly differentiated = looks very abnormal, usually faster.

Takeaway: hedging language ("suspicious for," "cannot exclude," "favor") is the pathologist being precise, not the pathologist being alarmed. If a phrase on your report is hedged, the right question is "what would it take to know for sure?"

How to read a surgical pathology report specifically

A surgical pathology report — generated after tissue is removed in an operating room, as opposed to a needle biopsy — is longer and carries more decision-making weight. Read it in this order rather than top to bottom:

1. Final diagnosis first. Skip to it. It's usually near the top or the very end, and it's the only section that summarizes everything.
2. Then margins. Clear, close, or positive — this determines whether more surgery is on the table.
3. Then node count. "X of Y nodes positive." The denominator matters too; a low number of nodes examined can mean the sampling was limited.
4. Then stage (pTNM). Now the earlier numbers have context.
5. Then the comment section. This is where the pathologist flags uncertainty, recommends further testing, or notes a close call.
6. Skip the gross and microscopic descriptions unless your doctor points you to them. They're working notes, not conclusions.

Takeaway: read a surgical pathology report bottom-line-first — diagnosis, margins, nodes, stage, comment. The dense middle sections rarely change what happens next.

How long pathology results take, and why yours might be delayed

A straightforward biopsy is usually finalized in 2 to 3 business days. A surgical specimen typically takes 3 to 7 days. Delays past that usually have a specific, benign explanation:

• Special stains or immunohistochemistry were ordered to distinguish between two possibilities — adds 1 to 3 days.
• Molecular or genetic testing (mutation panels, receptor testing) — adds 1 to 3 weeks, and often arrives as a separate addendum after the main report.
• Decalcification of bone or dense tissue — adds several days.
• A second pathologist's opinion was requested internally, which is a sign of care, not a sign of bad news.

If your report has been pending more than a week with no explanation, calling the ordering doctor's office and asking "is my pathology finalized, and is anything still pending?" is completely reasonable.

Takeaway: a delayed pathology report usually means extra testing, not worse news. Ask specifically whether anything is still pending rather than waiting in silence.

What the report usually does not tell you

A pathology report describes what was found. It does not explain:

• What to do about it
• What your specific treatment options are
• What your prognosis is
• What questions you should be asking

That interpretation happens in conversation with your care team — and it's reasonable to ask for that conversation to happen slowly enough that you actually understand it.

If a term is unfamiliar, ask specifically

The most useful question you can ask isn't "What does this all mean?" It's more surgical:

• "What does this specific word mean in my case?"
• "Which parts of this report drove your treatment recommendation?"
• "Is anything on this report borderline or open to interpretation?"
• "Should this be reviewed by a second pathologist?"

For anything cancer-related, a second pathology review at a major cancer center is common and often changes details of the diagnosis. If a second opinion would help, the NCI's guidance on getting one is a good place to start.

If you're staring at a report right now

You don't have to wait for your next appointment to start making sense of it. Paste in what your report says and Cura will walk through it in plain language — line by line — and generate the specific follow-up questions worth bringing to your care team. Not a generic checklist. The questions that actually match what's on your paper.

Ask Cura about your report →

Related reading

• What to ask after a breast cancer diagnosis — where your pathology report matters most in the first days after diagnosis.
• Questions to ask after any new diagnosis — the broader framework for the appointment where you'll discuss this report.
• Can AI help me understand my cancer diagnosis? — what AI is safe to use on a report like this, and the four things it should never be used for.
• What to ask after a heart disease diagnosis — a different disease area, same principle of asking about the underlying test results.

---

This post is for general informational purposes and isn't a substitute for guidance from your care team. Always confirm interpretation of your specific report with the physician who ordered it.